← Browse by Condition
Medical Condition

hiv 1 infection

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for hiv 1 infection sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hiv 1 infection Clinical Trials

How many clinical trials are currently recruiting for hiv 1 infection?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for hiv 1 infection, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hiv 1 infection?
hiv 1 infection research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hiv 1 infection clinical trial?
Eligibility criteria for hiv 1 infection trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
bioLytical Laboratories 1 trial
University College Dublin 1 trial
Castagna Antonella 1 trial
Gilead Sciences 1 trial
ANRS, Emerging Infectious Diseases 1 trial

Recruiting Clinical Trials

NCT07563309
Recruiting
A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
Enrollment
1,000 pts
Location
South Africa
Sponsor
bioLytical Laboratories
View Trial →
NCT04174755
Recruiting
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
Enrollment
80 pts
Location
Ireland
Sponsor
University College Dublin
View Trial →
NCT04098315
Recruiting
Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.
Enrollment
300 pts
Location
Italy
Sponsor
Castagna Antonella
View Trial →
NCT07645287 Phase 2
Recruiting
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Enrollment
175 pts
Location
United States, Austr...
Sponsor
Gilead Sciences
View Trial →
NCT06203132 Phase 3
Recruiting
DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection
Enrollment
610 pts
Location
Brazil, Cameroon, Cô...
Sponsor
ANRS, Emerging Infectious Dise...
View Trial →

Related Conditions

hiv 2 infection (1) syphilis infection (1) hepatitis b infection (1) obesity (1) multi antiviral resistance (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology